BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Steatotic liver disease
1
Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease
1/27/2026 10:12:30 AM | Browse: 69 | Download: 172
2
Steatotic liver disease in patients with chronic hepatitis C
12/26/2025 10:27:32 AM | Browse: 63 | Download: 331
3
Genetic predeterminants and recent advancements in steatotic liver disease: A roadmap toward precision hepatology
11/27/2025 7:53:58 AM | Browse: 66 | Download: 228
4
Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease
11/27/2025 7:53:53 AM | Browse: 51 | Download: 219
5
Microbiome and gut-liver interactions: From mechanisms to therapies
10/27/2025 8:08:12 AM | Browse: 160 | Download: 268
6
Impact of metabolic endoscopy on fibrosis regression in steatotic liver disease
9/25/2025 11:24:01 AM | Browse: 111 | Download: 175
7
Are we standing on the shifting sands of post-transplant metabolic-associated steatotic liver disease?
7/25/2025 12:09:47 PM | Browse: 149 | Download: 467
8
Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease
7/25/2025 12:09:44 PM | Browse: 107 | Download: 453
9
Evaluating the RESET care program: Advancing towards scalable and effective healthcare solutions for metabolic dysfunction-associated liver disease
4/25/2025 8:22:59 AM | Browse: 124 | Download: 411
10
Disparities in Liver Transplantation for Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Associated Hepatocellular Carcinoma
4/18/2025 8:22:03 AM | Browse: 115 | Download: 587
11
Patterns of dietary supplement use among United States patients with steatotic liver disease: Vitamins, minerals and botanicals
3/26/2025 4:06:51 AM | Browse: 91 | Download: 508
12
Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis
1/6/2025 8:47:56 AM | Browse: 112 | Download: 710
13
Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction
1/6/2025 8:47:56 AM | Browse: 123 | Download: 517
14
Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model
12/30/2024 6:47:30 AM | Browse: 120 | Download: 473
15
Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection
11/29/2024 2:50:17 PM | Browse: 246 | Download: 841
16
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker !
6/25/2024 10:41:21 AM | Browse: 202 | Download: 854
17
Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
6/20/2024 3:42:22 AM | Browse: 214 | Download: 597
18
Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
4/19/2024 3:18:01 AM | Browse: 142 | Download: 620
19
Liver biopsy in the post-hepatitis C virus era in Japan
4/12/2024 4:45:44 PM | Browse: 172 | Download: 895